Abstract Objective: To establish a collagen type II-induced rat model of rheumatoid arthritis (RA) presenting characteristics of the human form of the traditional Chinese syndrome pattern of toxic heat-stasis painful obstruction (bi zheng; arthromyodynia) as well as pathologic features of active RA. The Chinese herbal medicine Tengmei decoction was used to validate the animal model. Methods: Ninety specific pathogen free Sprague-Dawley rats were randomly divided into a normal group of 6 rats and a model group of 84 rats. To establish the rat model of collageninduced arthritis (CIA), bovine type II collagen in complete Freund's adjuvant was injected into the model group rats as a priming dose (Day 0) and boosting dose (Day 9). Changes in arthritic index (AI) scores, including limb swelling, were monitored. Thereafter, 24 successfullyestablished CIA rats were randomly assigned to 4 groups with 6 animals each: model, positive control drug, high-dose traditional Chinese herbal medicine, and traditional Chinese herbal medicine. A blank control group of 6 rats was included. After 12 weeks of intervention with Tengmei decoction, articular synovial tissue and serum specimens were collected to detect interleukin-2 (IL-2) and IL-17 transcription and protein expression levels.
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Introduction
Rheumatoid arthritis (RA) is a common immune-mediated inflammatory disease (IMID) that mainly affects joints and often leads to disability. Basic pathologic changes are chronic synovial inflammation manifesting as symmetric and erosive arthritis of peripheral joints, pannus formation, and cartilage destruction. In traditional Chinese medicine (TCM), RA is classified under the broad category of painful obstruction (bi zheng; arthromyodynia). However, each disease stage has different symptoms. For this reason, experimental models approximating specific pathologic stages of human RA are important for understanding the mechanism of RA and the mechanism of medications used to treat RA.
There are currently two main types of RA animal models: adjuvant-induced arthritis (AIA) and collagen-induced arthritis (CIA). 1 The AIA model is quite different from human RA, with lesions being self-limited in rats. In the rat CIA model, occurrence of a large number of lymphocytes infiltrating the synovium, and development of synovial hyperplasia, synovial cell swelling, and new vascular networks basically resemble the pathogenesis of human RA. Therefore, the CIA rat model is widely used in experimental studies on RA.
In this study, we used the CIA modeling approach to establish a rat model mimicking the characteristic symptoms of toxic heat-stasis type of painful obstruction with pathologic features of active RA. 4 To validate the animal model, the TCM herbal formula Tengmei decoction was administered to rats. Tengmei decoction is commonly prescribed in China to treat RA. Its TCM functions are to clear heat, resolve toxin, transform stasis, and remove turbidity with the treatment goal of alleviating systemic and local symptoms and improving abnormal serum indices of active RA. In this study, Tengmei decoction was used as the intervention control drug to test our hypothesis that the rat model of CIA mimics the TCM pattern of painful blockage. The effects of the formula were assessed by detecting its inhibition on immune and inflammatory markers in the joint synovium of rats.
Materials and methods

Experimental animals
A total of 90 specific pathogen free (SPF) Sprague-Dawley (SD) rats weighing 200e220 g were purchased from Vital River Laboratories (Beijing, China). All rats were housed in the barrier facility of the Institute of Chinese Materia Medica of the China Academy of Traditional Chinese Medical Sciences, Beijing. Conditions of the facility were 18e24 C and a relative humidity of 40e70%. Animals had free access to standard chow and tap water.
Reagents and instruments
Reagents: Bovine type II collagen (bovine CII) was purchased from Chondrex 
Grouping and model construction
Grouping Using a random number table, the 90 rats were divided into a normal group of 6 rats and a model group of 84 rats. All animals were fed adaptively for 1 week before model construction.
Solution preparation 0.1 M acetic acid: Under sterile conditions, 114 mL of glacial acetic acid was pipetted into a 50 mL centrifuge tube, into which 20 mL of sterile water for injection was added. The solution was gently mixed by vibrating. The resultant 0.1 M acetic acid solution was refrigerated at 4 C for later use. Bovine CII acetic acid solution: 15 mL of prepared 0.1 M acetic acid was added to 30 mg of frozen bovine CII powder. The solution was gently stirred in an ice bath until the collagen was completely dissolved, and the solution turned colorless and transparent. The resultant concentration was 2 mg/mL. The collagen solution was stored at 4 C away from light for later use. Bovine CII and CFA emulsion: Two 50 mLsyringes were used, one to draw 15 mL of prepared CII acetic acid solution and the other to draw 15 mL of CFA. The syringe needles were removed and the air in the syringes was expelled as much as possible. Tubing (approximately 4e5 cm) from an infusion set was used to connect the 2 syringes, resulting in a self-made emulsifier. In an ice bath, the CII acetic acid solution was first quickly emptied into the syringe containing CFA, and the mixed solution was then pushed back into the other syringe. This entire process was performed in an ice bath and was repeated. The tight connection between the tubing and syringes was monitored for leakage. When resistance of the syringes was significantly reduced upon pushing and the solution in the syringes became milky, a drop of the emulsified solution was removed and placed in clear water. Emulsification was considered complete when the emulsion drop floated on water without diffusing. The final concentration was 1 mg/mL. The emulsion was stored at 4 C away from light for later use.
Establishing CIA model of rheumatoid arthritis Model group rats were immunized with 200 mL of bovine CII-CFA emulsion (containing 200 mg of CII) by injection at the base of the tail. Booster immunization was performed 9 days later by injecting 100 mL of bovine II-CFA emulsion (containing 100 mg of CII). Rats in the normal control group were injected with an equal volume of saline.
Evaluating rheumatoid arthritis in rats
On Day 0 and starting 1 week after the booster dose was administered (16 days after immunization), CIA model rats were evaluated, including general appearance, body weight, and changes in the swelling of limbs. To measure limb swelling, a vernier caliper was used. Sites that were measured included thicknesses of the palm pads of both forelimbs, the wrist strip perpendicular to the palm (anterioreposterior diameter), the wrist strip between lateral points of the radius and ulna (lefteright diameter), footpads of both hindlimbs, between the posterior strip of the ankle and heel (anterioreposterior diameter), and between the high points of the medial and lateral aspects of the ankle (lefteright diameter).
Arthritis index (AI) was determined by the method per Chondrex 5 : 0 point, normal; 1 point, mild swelling of wrist/ ankle, swelling limited to a single joint, or a few joints; 2 points, moderate wrist/ankle swelling confined to a single wrist/ankle and not involving other interphalangeal joints; 3 points, severe wrist/ankle swelling affecting the paws (dorsum of the foot and metacarpophalangeal/metatarsophalangeal joints); 4 points, swelling of the entire limb affecting multiple joints. Rats with AI ! 4 were considered successful models.
Study on the mechanism of Tengmei Decoction in CIA model rats Grouping and intervention methods Twenty-four successfully-established CIA rats were randomly assigned to 4 groups with 6 animals in each: model, positive control drug, high-dose traditional Chinese medicine (TCM), and traditional Chinese medicine (TCM) groups. A normal control group of 6 rats was also included. The model and normal control groups were given distilled water (10 mL/kg per day). The positive control drug group was given leflunomide (LEF), an immunosuppressive disease-modifying anti-rheumatic drug (1.87 g/kg per day). The traditional Chinese medicine group was administered crude medicine (15.9 g/kg per day). The high-dose traditional Chinese medicine group received a dosage twice higher than that of the traditional Chinese medicine group. Animals in all groups were administered their respective substances by gavage. Dosages used in the positive and traditional Chinese medicine groups were equivalent to 5.6 times the human clinical dosages. Duration of the intervention study was 12 weeks. 0 . Real-time RT-PCR amplification was carried out using TRIzol reagent to extract the RNA in the synovial tissue of rats with the above primers. Reaction volume was 25 mL and the reaction system contained samples of RNA 2 mL, Power SYBR GREEN 17.2 mL, 10 pmol primer 0.8 mL. Reaction conditions were: 5 min at 42 C, 10 s at 95 C, 5 s at 95 C, extending at 34 s at 60 C, followed by 40 cycles. Using ELISA to detect IL-2 and IL-17 protein expression in serum of CIA model rats: ELISA assay was carried out according to manufacturer's instructions.
Statistical analysis
Measurements of AI and swelling between the model and normal groups at the same time points were compared using a t-test. Repeated measures ANOVA were used to analyze changes in the same indicator for the same group of rats at different time points. Levels of inflammatory factor were assessed using one-way analysis of variance. Statistical analyses were performed with SPSS 18.0 statistical software (IBM, Armonk, NY, USA).
Results
General observations
Following immunization, half of rats in the model group showed ulceration at the injection site at the base of the tail with an average area of 1 cm Â 1 cm. Normal tail movement was not affected, and severe lesions such as ring-shaped rupture or tail falling off were not observed. After 9 days, rats in the model group showed decreased appetite, slow movement, and matted fur. Ulceration and scab formation were observed at the injection site of the tail. After 16 days, rats in model group presented increased skin temperature, bright red skin, swollen joints, and limited mobility.
Changes in body weight
During Days 0 through 9, there was no significant difference in rat body weight between the normal and model groups (P > .05). By Day 16, body weights of model group animals had decreased significantly compared to normal group animals (P < .05) ( Table 1) .
Changes in swelling of limbs in the model group
Anterioreposterior and lateral diameters of forelimbs During Days 0 through 16, anterioreposterior and lateral diameters of the forelimbs in model group rats exhibited no significant difference from measurements of the normal control rats (P > .05) ( Table 2) .
Anterioreposterior and lateral diameters of hindlimbs During Days 0 through 9, the anterioreposterior and lefteright diameters of the hindlimbs in the model group did not differ significantly from the diameters of the normal control animals (P > .05). By Day 16, the anterioreposterior and lefteright diameters of the left hindlimbs in the model group were significantly larger than diameters of the normal control group (P < .01). The anterioreposterior diameters (P < .05) and lateral diameters (P < .01) of the right hindlimbs were significantly different from diameters of the normal group (Table 2) .
Footpad thicknesses
During days 0 through 9, footpad thicknesses of model group rats exhibited no significant difference when compared with normal group animals (P > .05). By Day 16, footpads of both left and right hindlimbs of model group rats were significantly thicker than those of the normal group (P < .05), and left forelimb footpads were markedly thicker than pads of the normal group rats (P < .01) ( Table 3) .
Arthritis index (AI) assessment
Severity of paw inflammation in the model group was obvious. Significant differences in total AI between the model and normal groups from Days 11 through 16 were observed (P < .01), especially AI of the left and right hindlimbs (P < .01). AI of the left and right forelimbs in the model group from Days 0 through 16 were not significantly different compared to the normal group (P > .05) (Tables 4).
Effects of Tengmei Decoction on inflammatory factors in CIA model rats
RT-PCR was used to detect levels of IL-2 and IL-17 mRNA transcription. ELISA was used to detect levels of IL-2 and IL-17 protein expression.
Effects on levels of IL-2 and IL-17 mRNA transcription
Compared to the normal control group, levels of IL-2 and IL-17 mRNA transcription were significantly upregulated in the model group (P < .01). Compared with the model group, levels of IL-2 and IL-17 mRNA transcription in the positive drug, high-dose TCM, and TCM groups were significantly upregulated (P < .01) ( Table 5) .
Effects of Tengmei Decoction on levels of IL-2 and IL-17 protein expression
Compared with the normal group, levels of IL-2 and IL-17 protein expression were significantly upregulated in the model group (P < .01) but were markedly decreased in the positive group, high-dose TCM group, and TCM group (P < .01) ( Table 6 ). 
Discussion
Establishment of experimental animal models resembling human diseases is an important aspect of medical research design and a long-standing deficiency affecting research. In recent years, animal models generated by genetic intervention have become available. Although enormous progress has been achieved, animal models for many human diseases remain lacking. With rheumatoid arthritis, a variety of autoantigens and their corresponding antibodies can be identified in serum and synovial fluid of patients, especially the type II collagen CII antibody. 6 Trentham and colleagues used bovine CII to successfully induce arthritis in rats, showing that collagen-induced arthritis in the rat model has characteristics of the autoimmune response found in human RA. 7 Since then, the CIA animal model has been improved and is still considered a classic model for studying human RA.
The aim of our study was to validate our hypothesis that clinical and pathologic features of the CIA rat model of rheumatoid arthritis resemble those of the TCM syndrome of toxic heat-stasis type painful obstruction. In our study, a modeling success rate of 83.3% was achieved, with 70 of 84 rats exhibiting AI ! 4. In terms of timing for administering the booster injection, the protocol by Chondrex indicates 7 days, 5 and other studies report 7e10 days after immunization. 8, 9 We observed that 7 days after immunization, a subset of rats began to exhibit redness of the toes, elevated skin temperature, and appearance of joint symptoms, similar to previously reported results. 10 We chose to administer the booster dose 9 days after the priming dose, which prevented the immune tolerance that occurs when the intervals between priming and boosting is short. This also avoided loss of the stimulating effect of the priming dose if boosting had been delayed.
Research suggests that immune imbalance between osteoblasts and osteoclasts, as well as osteoclast proliferation and activation are important factors of bone damage and bone metabolism disturbance, and the key to RA bone erosion. 11 Further studies suggest that monocytes, macrophages, and T lymphocytes can express a variety of cytokines functioning in the growth, activation, and apoptosis of osteoclasts, of which tumor necrosis factor-alpha (TNFa), IL-1, IL-2, IL-6, and IL-17 directly or indirectly act on osteoclasts and mediate osteoclast differentiation. 12, 13 More important, activation of inflammatory mediators are involved in the occurrence and development of synovial lesions. 14, 15 In particular, IL-2 expression has been found to be increased when the degree of RA disease activity is Normal 6 0.00 AE 0.00 0.00 AE 0.00 0.00 AE 0.00 0.00 AE 0.00 0.00 AE 0.00 0.00 AE 0.00 0.00 AE 0.00 0.00 AE 0. enhanced. 16 IL-2 interacts with TNF-a, IL-6, and IL-17 cytokines to aggravate RA inflammation. Furthermore, in the mice model of CIA, level of IL-2 expression varies during different stages, such that in the early stages of RA, IL-2 is markedly increased. 17 As a powerful inflammatory factor, IL-17 can induce expression of proinflammatory cytokines, such as IL-6, IL-1b, TNF-a, monocyte chemotactic protein 1 (MCP-1), and granulocyte-macrophage colony-stimulating factor GM-CSF, as well as promote proliferation, maturation, and neutrophil chemotaxis. IL-17 can also increase expression of intercellular adhesion molecule 1 (ICAM-1), which mediates inflammatory cells and T cell infiltration in tissue. IL-17 interacts with IL-1b, TNF-a, and interferon gamma (IFN-g) to amplify target organ immune response and inflammatory damage. IL-17 participates in the pathogenesis of autoimmune diseases and various infections by the aforementioned effects. 18, 19 Therefore, immune damage mediated by inflammatory cytokines is involved in the course of RA, especially during the active stage. Clinically active RA is characterized by systemic and local inflammatory responses and major presentations are accelerated erythrocyte sedimentation rate, elevated C-reactive protein, cyclic citrullinated peptide, and rheumatoid factor, local joint swelling, elevated skin temperature, dark red skin, edema, and increased joint pain. Finally, large numbers of inflammatory cells, such as T cells, B cells, and macrophages, as well as expressed inflammatory cytokines, accumulate in the synovial fluid, validating that the CIA model presents typical features of active RA.
In Chinese medicine, painful blockage (bi zheng) is a class of syndrome patterns caused by the pathogenic factors of wind, cold, dampness, or heat which invade the channels and blood. If unresolved, the main symptoms are joint and muscle pain. There are several patterns of painful blockage depending on the symptomatology. Toxic heatblood stasis is one such pattern. Its pathogenic mechanisms are excess toxic heat, heat affecting the internal organs, constrained qi and blood, all of which lead to slow stasis (blockage) in the joints. In this study, we used the traditional Chinese herbal formula, Tengmei Decoction, to test our hypothesis that the rat model of CIA mimics the Chinese medicine pattern of painful blockage. Tengmei decoction is widely prescribed in China to treat RA. Its traditional functions are to clear heat, resolve toxin, transform stasis, and remove turbidity. Our results showed that the CIA model rats presented acute inflammation with synovial symptoms, such as varying degrees joints swelling, dark red skin, and increased temperature, which all improved after the 12 weeks' treatment with Tengmei Decoction. Meanwhile, the levels of IL-2 and IL-17 mRNA transcription and protein expression decreased significantly compared with the model group after the 12 weeks' treatment with Tengmei Decoction. This was consistent with outcomes of our previous study showing Tengmei decoction downregulated levels of IL-6 and TNF-a mRNA transcription and protein expression. 20 Both studies thus appear to indicate that the CIA rat model of RA presents pathologic and physiologic features of active RA and characteristics of toxic heat-stasis painful blockage.
Limitations of our study are that in this animal model we did not investigate articular cartilage and bone damage as well as other pathologic changes found in late stage RA and whether these changes can in fact be observed in this animal model. These require future exploration.
Conclusion
The CIA model established in this study presents both active RA pathologic features and characteristics of the symptoms of toxic heat-stasis painful obstruction 12 weeks after successful establishment of an animal model. In addition, this study may be a valuable reference for development of animal studies with combined Eastern and Western medicines in dialectics and identification of diseases.
